Why the study?
The diagnostic performance of unattended automated office blood pressure measurement for hypertension screening in low-income settings has not been determined.
Does unattended automated office blood pressure measurement accurately screen for hypertension compared to 24-hour ambulatory blood pressure monitoring in Kenyan adults?
Does unattended automated office blood pressure measurement accurately screen for hypertension compared to 24-hour ambulatory blood pressure monitoring in Kenyan adults?
Unattended automated office blood pressure measurement has wide limits of agreement and low sensitivity compared to 24-hour ambulatory monitoring, misclassifying a significant proportion of individuals screened for hypertension in Kenya.
uAOBP validity for hypertension screening in low-income Kenyan adults remains uncertain; leaves open routine adoption pending prospective validation.
Despite increasing adoption of unattended automated office blood pressure (uAOBP) measurement for determining clinic blood pressure (BP), its diagnostic performance in screening for hypertension in low-income settings has not been determined. We determined the validity of uAOBP in screening for hypertension, using 24-hour ambulatory BP monitoring as the reference standard. We studied a random population sample of 982 Kenyan adults; mean age, 42 years; 60% women; 2% with diabetes mellitus; none taking antihypertensive medications. We calculated sensitivity using 3 different screen positivity cutoffs (≥130/80, ≥135/85, and ≥140/90 mm Hg) and other measures of validity/agreement. Mean 24-hour ambulatory BP monitoring systolic BP was similar to mean uAOBP systolic BP (mean difference, 0.6 mm Hg; 95% CI, −0.6 to 1.9), but the 95% limits of agreement were wide (−39 to 40 mm Hg). Overall discriminatory accuracy of uAOBP was the same (area under receiver operating characteristic curves, 0.66–0.68; 95% CI range, 0.64–0.71) irrespective of uAOBP cutoffs used. Sensitivity of uAOBP displayed an inverse association ( P <0.001) with the cutoff selected, progressively decreasing from 67% (95% CI, 62–72) when using a cutoff of ≥130/80 mm Hg to 55% (95% CI, 49–60) at ≥135/85 mm Hg to 44% (95% CI, 39–49) at ≥140/90 mm Hg. Diagnostic performance was significantly better ( P <0.001) in overweight and obese individuals (body mass index, >25 kg/m 2 ). No differences in results were present in other subanalyses. uAOBP misclassifies significant proportions of individuals undergoing screening for hypertension in Kenya. Additional studies on how to improve screening strategies in this setting are needed.
No takes yet. Share an insight, caveat, or question.
Etyang et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: